0001493152-22-007381.txt : 20220321 0001493152-22-007381.hdr.sgml : 20220321 20220321172636 ACCESSION NUMBER: 0001493152-22-007381 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220321 DATE AS OF CHANGE: 20220321 EFFECTIVENESS DATE: 20220321 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curative Biotechnology Inc CENTRAL INDEX KEY: 0001400271 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 721550658 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-438256 FILM NUMBER: 22756502 BUSINESS ADDRESS: STREET 1: 1825 NW CORPORATE BLVD STREET 2: SUITE 110 CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 800-526-8006 MAIL ADDRESS: STREET 1: 1825 NW CORPORATE BLVD STREET 2: SUITE 110 CITY: BOCA RATON STATE: FL ZIP: 33431 FORMER COMPANY: FORMER CONFORMED NAME: Connectyx Technologies Corp DATE OF NAME CHANGE: 20070522 D 1 primary_doc.xml X0708 D LIVE 0001400271 Curative Biotechnology Inc 1825 NW CORPORATE BLVD SUITE 110 BOCA RATON FL FLORIDA 33431 (561) 907-8990 FLORIDA Connectyx Holdings Group Technologies, Inc. Connectyx Technologies Corp Corporation true Garr Richard 1825 NW Corporate Blvd Suite 110 Boca Raton FL FLORIDA 33431 Executive Officer Barry Ginsberg 1825 NW Corporate Avenue Suite 110 Boca Raton FL FLORIDA 33431 Executive Officer Director Paul Michaels 1825 NW Corporate Avenue Suite 110 Boca Raton FL FLORIDA 33431 Executive Officer Director Michael Fish 1825 NW Corporate Avenue Suite 110 Boca Raton FL FLORIDA 33431 Director Pharmaceuticals Decline to Disclose 06b false 2022-03-04 false true true true false 1000000 Aegis Capital Corp. 15007 None None 810 7TH AVENUE 18TH AND 22ND FLOOR NEW YORK NY NEW YORK 10019 NY NEW YORK false 1000000 1000000 0 Original Issue Discount Convertible Note ($1,142,857) and Warrant false 1 102500 0 0 false Curative Biotechnology Inc /s/ Richard Garr Richard Garr CEO 2022-03-21